Unsurprisingly, China’s Omicron wave has cut growth, dragging down emerging market stock values. But current valuations are a reflection of recent challenges rather than a sign of things to come, as China looks to ease monetary policy and step up its vaccination drive. ⌘ Read more
Unsurprisingly, China’s Omicron wave has cut growth, dragging down emerging market stock values. But current valuations are a reflection of recent challenges rather than a sign of things to come, as China looks to ease monetary policy and step up its vaccination drive. ⌘ Read more